Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Avania | INDUSTRY |
Not provided
Not provided
Not provided
A post market clinical study to confirm the performance and safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter on patients undergoing surgical treatment for the removal of arterial emboli and/or thrombi
This prospective, single arm, post market clinical study was designed to proactively collect clinical data on the LeMaitre® TufTex Single Lumen Embolectomy Catheters and to confirm its performance in removing arterial emboli and/or thrombi, to identify and analyze emergent risks on the basis of factual evidence, and to ensure the continued acceptability of the benefit/risk ratio. This post market study is sponsored by LeMaitre® Vascular, Inc., the manufacturer of the device. Study will take place at 3 to 8 sites in Europe, the target sample size is 112 patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| LeMaitre TufTex Single Lumen Embolectomy Catheter | Other | The LeMaitre® Single Lumen Embolectomy Catheter is a catheter that consists of a natural latex rubber balloon secured with ligatures to a single lumen radiopaque shaft. When the balloon the emboli and/or thrombi can be removed by withdrawing the catheter tip through the arteriotomy. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| TufTex Single Lumen Embolectomy Catheter | Device | The SLC Embolectomy Catheter is indicated for the removal of arterial emboli and thrombi |
|
| Measure | Description | Time Frame |
|---|---|---|
| Safety objective is defined as acceptable safety outcomes (e.g. (Serious) Device and/or Procedure Related Events) during the procedure | The primary safety objective is defined as acceptable safety outcomes (e.g. (Serious) Device and/or Procedure Related Events) during the procedure and 1 Month post index procedure. | During procedure and 1 month post index procedure |
| Performance objective is the technical success as defined as <30% residual stenosis | The primary performance objective is the technical success as defined as <30% residual stenosis of the target vessel. | 1 month post index procedure |
| Measure | Description | Time Frame |
|---|---|---|
| 1. Clinical success | Clinical success is target vessel dependent and defined as; (1) The absence of target vessel limb amputation post-intervention in case of limb cloths, and 2. successful dialysis sessions performed post-intervention in case of dialysis shunt revascularization (2) Revision rate is defined as the number of patients with target vessel reintervention (3) Primary assisted patency is defined as target vessel patency; the target vessel is patent but there may have been some intervention required to maintain that patency. (4) Secondary patency is defined as the target vessel patency including target vessel that have been occluded and there has been an intervention to restore patency. |
| Measure | Description | Time Frame |
|---|---|---|
| Exploratory endpoints | Number of LeMaitre® Embolectomy Catheters used per intervention Number of balloon tears per intervention. | 1 month post index procedure |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Andrew Hodgkinson | Contact | 781-425-1664 | ahodgkinson@lemaitre.com | |
| Brian Orrick | Contact | 7814251685 | borrick@lemaitre.com |
| Name | Affiliation | Role |
|---|---|---|
| Giorgio Prouse | Ospedale Regionale di Lugano - sede Civico | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ziekenhuis Oost-Limburg | Recruiting | Genk | Belgium |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 1 Month after the index procedure |
| 2. Revision Rate | Revision rate is defined as the number of patients with target vessel reintervention | 1 month post index procedure |
| 3. Primary Assisted Patency | Primary assisted patency is defined as target vessel patency; the target vessel is patent but there may have been some intervention required to maintain that patency. | 1 month post index procedure |
| 4. Secondary Patency | Secondary patency is defined as the target vessel patency including target vessel that have been occluded and there has been an intervention to restore patency. | 1 month post index procedure |
| Andrej Udelnow | Recruiting | Brandenburg | Germany |
|
| Giorgio Prouse | Not yet recruiting | Lugano | Switzerland |
|